Journal of Clinical Endocrinology & Metabolism, Vol 65, 689-696, Copyright © 1987 by Endocrine Society

ARTICLES

Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration

KB Ain, Y Mori and S Refetoff
Department of Medicine, University of Chicago, Illinois 60637.

Hyperestrogenemic states, including pregnancy, cause an increase in serum T4-binding globulin (TBG) concentrations and an increase in the proportion of TBG molecules with greater anodal mobility on isoelectric focusing, indicating greater sialic acid content. The possible causal relationship between the degree of sialylation and accumulation of TBG in serum was explored by measuring the in vivo half-lives (t1/2) of TBGs with different isoelectric points. TBG in unfractionated serum and its major peaks, isolated by chromatofocusing and defined by their isoelectric points on isoelectric focusing were each injected iv into rats. The resulting TBG concentrations, measured by specific RIA in serum samples obtained at intervals after injection, were used for the calculation of the t1/2. TBG in serum from a pregnant woman had a significantly longer t1/2 of 17.2 +/- 1.2 h (mean +/- SD) compared to those of 13.3 +/- 1.5 and 12.9 +/- 0.9 h for TBG in serum from a man and a nonpregnant woman, respectively. TBG peaks II, III, IV, and V, with increasing anodal mobility, had progressively longer t1/2 values of 11, 13, 15, and 33 h, respectively. However, TBG peaks of the same mobility on IEF isolated from serum of pregnant or nonpregnant subjects had similar t1/2 values. Neither the TBG concentration nor estrogen had a direct effect on the rate of TBG clearance. Indeed, the t1/2 of TBG from a subject with inherited TBG excess was not different from that of TBG from a nonpregnant woman or a man. Chronic treatment of rats with estradiol did not alter the rate of clearance of injected human TBG. Finally, the more heavily sialylated anodal bands of purified but unfractionated serum TBG, analyzed by Western blots, survived longer in the circulation of a rat. These results indicate that the rate of in vivo metabolism of TBG is dependent on its sialic acid content. The increased proportion of TBG molecules with higher sialic acid content thus contributes to the increase in the serum TBG concentration in hyperestrogenemic states.

This article has been cited by other articles:

				J. L. Shifren, N. Rifai, S. Desindes, M. McIlwain, G. Doros, and N. A. Mazer A Comparison of the Short-Term Effects of Oral Conjugated Equine Estrogens Versus Transdermal Estradiol on C-Reactive Protein, Other Serum Markers of Inflammation, and Other Hepatic Proteins in Naturally Menopausal Women J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1702 - 1710. [Abstract] [Full Text] [PDF]

				Hypothyroidism in the pregnant woman DTB, July 1, 2006; 44(7): 53 - 56. [Abstract] [Full Text] [PDF]

				P. H Bisschop, A. W Toorians, E. Endert, W. M Wiersinga, L. J Gooren, and E. Fliers The effects of sex-steroid administration on the pituitary-thyroid axis in transsexuals. Eur. J. Endocrinol., July 1, 2006; 155(1): 11 - 16. [Abstract] [Full Text] [PDF]

				R. T. Zoeller, R. Bansal, and C. Parris Bisphenol-A, an Environmental Contaminant that Acts as a Thyroid Hormone Receptor Antagonist in Vitro, Increases Serum Thyroxine, and Alters RC3/Neurogranin Expression in the Developing Rat Brain Endocrinology, February 1, 2005; 146(2): 607 - 612. [Abstract] [Full Text] [PDF]

				E. K. Alexander, E. Marqusee, J. Lawrence, P. Jarolim, G. A. Fischer, and P. R. Larsen Timing and Magnitude of Increases in Levothyroxine Requirements during Pregnancy in Women with Hypothyroidism N. Engl. J. Med., July 15, 2004; 351(3): 241 - 249. [Abstract] [Full Text] [PDF]

				S. H.-J. Hsu, W.-C. Cheng, M.-W. Jang, and K.-S. Tsai Effects of Long-Term Use of Raloxifene, a Selective Estrogen Receptor Modulator, on Thyroid Function Test Profiles Clin. Chem., October 1, 2001; 47(10): 1865 - 1867. [Full Text] [PDF]

				B. M. Arafah Increased Need for Thyroxine in Women with Hypothyroidism during Estrogen Therapy N. Engl. J. Med., June 7, 2001; 344(23): 1743 - 1749. [Abstract] [Full Text] [PDF]

				R. D. Utiger Estrogen, Thyroxine Binding in Serum, and Thyroxine Therapy N. Engl. J. Med., June 7, 2001; 344(23): 1784 - 1785. [Full Text] [PDF]

				E. Marqusee, L. E. Braverman, J. E. Lawrence, J. S. Carroll, and E. W. Seely The Effect of Droloxifene and Estrogen on Thyroid Function in Postmenopausal Women J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4407 - 4410. [Abstract] [Full Text]

				A. G. DOUFAS and G. MASTORAKOS The Hypothalamic-Pituitary-Thyroid Axis and the Female Reproductive System Ann. N.Y. Acad. Sci., April 1, 2000; 900(1): 65 - 76. [Abstract] [Full Text] [PDF]

				O. E. Janssen, S. T. Astner, H. Grasberger, S. K. Gunn, and S. Refetoff Identification of Thyroxine-Binding Globulin-San Diego in a Family from Houston and Its Characterization by in Vitro Expression Using Xenopus Oocytes J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 368 - 372. [Abstract] [Full Text]

				P. Cousin, H. Déchaud, C. Grenot, H. Lejeune, M. Pugeat with the technical assistance of, C. Baret, and C. Brébant Human Variant Sex Hormone-Binding Globulin (SHBG) with an Additional Carbohydrate Chain Has a Reduced Clearance Rate in Rabbit J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 235 - 240. [Abstract] [Full Text]

				C. Grunfeld, W. Doerrler, M. Pang, P. Jensen, K. H. Weisgraber, and K. R. Feingold Abnormalities of Apolipoprotein E in the Acquired Immunodeficiency Syndrome J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3734 - 3740. [Abstract] [Full Text] [PDF]

				D. Glinoer The Regulation of Thyroid Function in Pregnancy: Pathways of Endocrine Adaptation from Physiology to Pathology Endocr. Rev., June 1, 1997; 18(3): 404 - 433. [Abstract] [Full Text]

				G. N. Burrow, D. A. Fisher, and P. R. Larsen Maternal and Fetal Thyroid Function N. Engl. J. Med., October 20, 1994; 331(16): 1072 - 1078. [Full Text]